Cargando…
Analytical and clinical characterization of an optimized dual monoclonal sandwich ELISA for the quantification of thymidine kinase 1 (TK1) protein in human blood samples
Thymidine Kinase 1 (TK1) plays an important role in DNA precursor synthesis and serum TK1 activity has been used as a biomarker for prognosis and therapy monitoring of different malignancies. AroCell has developed a dual monoclonal antibody ELISA for determination of TK1 protein in clinical samples....
Autores principales: | Jagarlamudi, K. K., L., Swinkels, M., Zupan, J., Osredkar, P., Venge, S., Eriksson |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536554/ https://www.ncbi.nlm.nih.gov/pubmed/36201558 http://dx.doi.org/10.1371/journal.pone.0275444 |
Ejemplares similares
-
A monoclonal antibody-based sandwich ELISA for measuring canine Thymidine kinase 1 protein and its role as biomarker in canine lymphoma
por: Sharif, Hanan, et al.
Publicado: (2023) -
A New Sandwich ELISA for Quantification of Thymidine Kinase 1 Protein Levels in Sera from Dogs with Different Malignancies Can Aid in Disease Management
por: Jagarlamudi, Kiran Kumar, et al.
Publicado: (2015) -
Properties of cellular and serum forms of thymidine kinase 1 (TK1) in dogs with acute lymphocytic leukemia (ALL) and canine mammary tumors (CMTs): implications for TK1 as a proliferation biomarker
por: Jagarlamudi, Kiran Kumar, et al.
Publicado: (2014) -
Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker
por: Jagarlamudi, Kiran Kumar, et al.
Publicado: (2015) -
A clinical evaluation of the TK 210 ELISA in sera from breast cancer patients demonstrates high sensitivity and specificity in all stages of disease
por: Kumar, J. Kiran, et al.
Publicado: (2016)